Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 EX-1.1
- 2.1 EX-2.1
- 3.1 EX-3.1
- 3.4 EX-3.4
- 4.2 EX-4.2
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3A
- 10.3 EX-10.3B
- 10.3 EX-10.3C
- 10.4 EX-10.4A
- 10.4 EX-10.4B
- 10.5 EX-10.5A
- 10.5 EX-10.5B
- 10.6 EX-10.6(A)
- 10.6 EX-10.6(B)
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 21.1 EX-21.1
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
Associated filings
RVMD similar filings
Filing view
External links
Exhibit 23.3
Consent of Independent Auditors
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 30, 2017 (except for Notes 7, 8 and 13, as to which the date is September 19, 2019), with respect to the financial statements of Warp Drive Bio, Inc. included in this Registration Statement on FormS-1 and related Prospectus of Revolution Medicines, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
January 17, 2020